Avaxim is a vaccine for hepatitis A, which has a low dose volume of only 0.5 ml. The vaccine is administered in two doses at 6 to 12 months’ interval. Avaxim is approved for use with persons 16 years and older.
Avaxim is delivered ready for use in pre-filled syringes with fixed needles. Avaxim may safely be administered as a second dose to those who have received another hepatitis A vaccine for their first dose.
Epaxal is a modern vaccine for hepatitis A, which doesn’t contain the usual excipients such as aluminum, preservatives or antibiotics. Epaxal has been shown to produce fewer local side effects than traditional aluminum-adsorbed hepatitis A vaccines. Epaxal is approved for use with persons ages 1 year and older. The vaccine is administered in two 0.5 ml doses, preferably at an interval of 6 to 12 months. Epaxal may safely be administered as a second dose to those who have received another vaccine as their first dose.
HBvaxPRO is a modern vaccine for hepatitis B that is free from mercury. HBvaxPRO is normally administered in three 1 ml doses (at 0, 1 and 6 months). It can be given as a primary immunization, or HBvaxPRO may be given as a booster to persons who have previously received a different hepatitis B vaccine.